Technology Platform Validic Acquires Infometers July 9, 2014 The deal provides the company’s clients with a larger variety and number of device integrations. Read More
DEA Considers Tramadol a Schedule IV Controlled Substance July 9, 2014 Determination creates new requirements for drugmakers. Read More
InspireMD Completes Trial of Carotid Embolic Protection System July 8, 2014 The CE-marked system uses the same technology as the company’s MGuard stents. Read More
Orexo and Actavis Fighting Over Zubsolv July 8, 2014 Activis is attempting to market a generic version of the Orexo opioid treatment. Read More
Mainstay Medical Submits Pre-IDE Info Package to the FDA for ReActive8 July 7, 2014 The company hopes to get feedback on elements for a future investigational device submission for its sole product. Read More
Amgen’s Cancer Treatment Receives FDA Breakthrough Therapy Designation July 7, 2014 The bispecific T cell engager (BiTE) antibody blinatumomab is for the treatment of a rapidly progressing blood and bone marrow cancer. Read More
Exactech’s Optetrak Logic Porous Coating Launches Internationally July 3, 2014 The coating covers knee implants for total knee replacement. Read More
ViiV Healthcare’s Triumeq for HIV Gets CHMP Nod July 3, 2014 Move puts the company’s investigational drug one step closer to launch. Read More
Dallen Medical Gains 510(k) Clearance for Disposable Staple System July 2, 2014 The Compressyn staple delivery system is designed for small bone fixation. Read More
Teva, GSK Try to Apply Pom Wonderful Ruling to False-Ad Lawsuit July 2, 2014 The Supreme Court noted the distinction between food and drug labeling. Read More
Massachusetts Enacts Biosimilar Substitution Law July 1, 2014 The state joins seven others in passing a law to allow pharmacists to substitute a biosimilar for a branded biological product. Read More
Spectranetics Acquires Cardiovascular Balloon Maker AngioScore July 1, 2014 The deal is for $230 million in cash plus milestone payments. Read More